Literature DB >> 11724353

Epidermal growth factor receptor structure, regulation, mitogenic signalling and effects of activation.

P Boulougouris1, J Elder.   

Abstract

The biological effects of epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) are mediated by an interaction with a specific cell surface receptor having both intra- and extracellular domains. The structure of the intracellular domain can be closely aligned with retroviral protein tyrosine kinases. Upon ligand-binding there is a change in conformation of the extracellular domain, the receptor being converted to dimeric. Dimeric receptor has a higher rate of catalysis than monomeric and rapidly becomes phosphorylated. This form of the receptor now associates with and phosphorylates enzymes such as phospholipase-C, altering their catalytic activity and subcellular distribution This system appears to stimulate the effects of epidermal growth factor receptor(EGFr) activation, notably proliferation, morphology, paracrine effects and differentation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724353

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Non-small cell lung cancer: the era of targeted therapy.

Authors:  Mara B Antonoff; Jonathan D'Cunha
Journal:  Lung Cancer (Auckl)       Date:  2012-07-02

2.  Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.

Authors:  Catia Cemeus; Tong T Zhao; Gordon M Barrett; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

3.  Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors.

Authors:  Tong T Zhao; Diane Trinh; Christina L Addison; Jim Dimitroulakos
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

4.  Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury.

Authors:  Sonia Podvin; Ana-Maria Gonzalez; Miles C Miller; Xitong Dang; Hannah Botfield; John E Donahue; Arwa Kurabi; Matthew Boissaud-Cooke; Ryan Rossi; Wendy E Leadbeater; Conrad E Johanson; Raul Coimbra; Edward G Stopa; Brian P Eliceiri; Andrew Baird
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

5.  Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.

Authors:  Wei-Ling Lin; Yi-Shiuan Lin; Guey-Yueh Shi; Chuan-Fa Chang; Hua-Lin Wu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.